Steve Shum, INVO BioScience, Inc.'s Chief Executive Officer and a director of the company, just received 180,000 options from the company. The strike price of the options received was $3.06, and these expire on December 31, 2030. Shum now owns at least 180,000 options on the company.
Some additional info was provided as follows:
The option vests in equal monthly increments over a period of three years from the grant date.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever INVO BioScience, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Notice of Effectiveness - April 16, 2021
Current report, items 1.01, 8.01, and 9.01 - April 13, 2021
Registration statement under Securities Act of 1933 - April 7, 2021
Invo Bioscience Reports 2020 Financial Results - March 30, 2021